Moneycontrol
    Moneycontrol PRO
    FiDEX 2026
    FiDEX 2026

    Drugmakers fall on government price control policy

    The policy, which will curtail prices of costly brands sold by domestic and international drugmakers, was approved by the government in November.

    May 17, 2013 / 12:24 IST

    The NSE Pharma index falls 0.93 percent after the government formally notified a new drug pricing policy designed to increase the number of drugs deemed essential that are subject to price caps.

    Also Read: Drug pricing regime comes into effect; pharma stocks mixed

    The policy, which will curtail prices of costly brands sold by domestic and international drugmakers, was approved by the government in November. Glenmark Pharmaceuticals Ltd falls 1.68 percent, Ranbaxy Laboratories Ltd slips 1.65 percent, while Dr.Reddy's Laboratories Ltd declines 1.68 percent.

    Cipla Ltd is down 0.94 percent and Lupin Ltd falls 1.04 percent.

    first published: May 17, 2013 11:48 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347